Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to evaluate whether a short interactive video game device is associated with performance on standard measures of attention and problem solving in patients with systemic lupus erythematosus(SLE). The study is also designed to see if playing the video game for four weeks improves attention and problem solving in patients with SLE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2018
CompletedFirst Submitted
Initial submission to the registry
November 1, 2018
CompletedFirst Posted
Study publicly available on registry
November 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedJanuary 13, 2020
January 1, 2020
1.3 years
November 1, 2018
January 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in mean response time on EVO Monitor
Average response time (ms) to in game stimuli
30 Days
Change in response time variability on EVO Monitor
Compares response time (ms) while single and multi- tasking in EVO game play
30 Days
Change in EVO performance threshold
Calculation of performance when participant is single vs. multi-tasking
30 days
Change in Digit Vigilance Test Scores
This task measures attention. Scores are based on number of targets found and time to completion. Scores are converted to a t-score based on demographically corrected normative data.
30 Days
Change in Trail Making Test Scores
This is a test of visual attention and task switching. Scores are based on time to completion and number of errors made. Scores are converted to a t-score based on demographically corrected normative data.
30 days
Change in Stroop Test Scores
This examines cognitive flexibility. The participant reads color words or names ink colors from different pages as quickly as possible within a time limit. The test yields three scores based on the number of items completed on each of the three stimulus sheets as well as in interference score. Scores are converted to a t-statistic based on demographically corrected normative data.
30 days
Change in Digit Symbol Substitution Scores
The participant scans a key and draws the correct symbol below a the corresponding number. Number of symbols drawn in 120 seconds is converted to a t-statistic using demographically corrected normative data.
30 days
Study Arms (2)
Project EVO Multi- Treatment
EXPERIMENTALTreatment group receives video game device treatment. Participant plays the game for 30 minutes a day, at least five days a week for four weeks.
Control
NO INTERVENTIONNo contact control
Interventions
The EVO platform assesses perceptual discrimination while single-and multi-tasking. Visuomotor tracking involves navigating a character through a dynamically moving environment while avoiding obstacles. EVO uses adaptive algorithms to change game difficulty on a trial by trial and patient by patient basis for the tracking task and discrimination task with real-time feedback.
Eligibility Criteria
You may qualify if:
- Diagnosis of SLE
You may not qualify if:
- Major neurological problems (head trauma, degenerative vascular or metabolic disorder; neoplasm or toxic exposure) prior to SLE
- Major psychiatric disorder prior to SLE
- Major substance abuse
- Pregnant
- Major motor impairment
- High SLE disease activity
- History of learning disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Jewish Healthlead
- Novartis Pharmaceuticalscollaborator
- Akili Interactive Labs, Inc.collaborator
Study Sites (1)
Natinal Jewish Health
Denver, Colorado, 80220, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2018
First Posted
November 19, 2018
Study Start
June 6, 2018
Primary Completion
September 30, 2019
Study Completion
July 1, 2020
Last Updated
January 13, 2020
Record last verified: 2020-01